Polyplus (part of Satorius) company, Xpress Biologics, has received a good manufacturing practice (GMP) c...
Epsilogen, a leading immunoglobulin E (IgE) antibodies developer treating cancer, and global biopharma leader Lonza have...
Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapie...
With investments of approximately one billion euros, Japan headquartered Daiichi Sankyo will expand its production and ...
The Eppendorf Innovation Company (EpIC) – a division of Eppendorf SE – continues to expand its interna...
UK-based University of Dundee’s Drug Discovery Unit has announced a renewed partnership with Japanese pharmaceut...
SGD Pharma, global market leader in molded glass primary packaging solutions for the pharmaceutical industry, announces ...
SGD Pharma has announced the opening of a new siliconisation operation at its state-of-the-art Saint-Quentin Lamott...
Paris-headquartered international medtech firm, VirtualiSurg has created an immersive mediverse – a virtual learni...
Merck, a leading science and technology company, has announced a licensing agreement with US-based firm Inspirna, Inc. f...
Swiss firm Roche has announced the entry into a definitive agreement to acquire select parts of the UK-based LumiraDx gr...
Denmark-based Novo Nordisk Foundation is committing up to DKK 1.8 billion ($260 million) to establish a state-...
London Biotechnology Show 2024 is a highly anticipated event scheduled for May 8th and 9th at Olympia West. The event is...
After joining forces in a $12.3 billion merger, Denmark headquartered bioscience companies Novozymes and Chr. Hansen hav...
The multi-target research and development partnership will focus on severe skin diseases • &nbs...
US-based Revvity, Inc. has announced the launch of its EONIS™ Q system, a CE-IVD declared platform ...
Pharmaceutical 3D screen printing company Laxxon Medical has been selected alongside seven other high-potential companie...
The US Food and Drug Administration (FDA) has approved Ixchiq, the first chikungunya vaccine, developed by Valneva ...
